Latest news
StockWatch: Lilly Rises on Revenue Leap; Analysts High on Krystal Despite Revenue Miss - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Mon, 10 Aug 2026 04:37:02 GMTEli Lilly (LLY) Posts Blowout Growth And Raises Its Outlook - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 08:51:11 GMTLilly Says Weight Loss Drug Prices Fell 13 Percent Worldwide, but the US Decline Was Far Smaller - inklinkl · Thu, 06 Aug 2026 11:40:08 GMTLilly surges on Mounjaro, zepbound as revenue jumps and outlook rises - CHOSUNBIZ - ChosunbizChosunbiz · Thu, 06 Aug 2026 01:01:00 GMTLilly beats estimates on resilient demand for injectable GLP-1 drugs, widens gap with Novo - ReutersReuters · Wed, 05 Aug 2026 17:51:09 GMTNovo CEO looks to speed up R&D as share drop shows gap with Lilly - ReutersReuters · Wed, 05 Aug 2026 15:33:40 GMTEli Lilly raises 2026 estimates, Mounjaro and Zepbound boom - firstonline.infofirstonline.info · Wed, 05 Aug 2026 13:58:24 GMTEli Lilly Stock Rises as GLP-1 Demand Drives Beat-and-Raise - Schaeffer's Investment ResearchSchaeffer's Investment Research · Wed, 05 Aug 2026 13:21:15 GMT